KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other financing activities (2016)

Novavax (NVAX) has 5 years of Other financing activities data on record, last reported at $10.8 million in Q4 2016.

  • For Q4 2016, Other financing activities rose 8459.52% year-over-year to $10.8 million; the TTM value through Sep 2017 reached $10.8 million, up 1656.28%, while the annual FY2016 figure was $10.0 million, N/A changed from the prior year.
  • Other financing activities reached $10.8 million in Q4 2016 per NVAX's latest filing, up from -$10.8 million in the prior quarter.
  • Across five years, Other financing activities topped out at $11.6 million in Q1 2015 and bottomed at -$10.8 million in Q3 2016.
  • Average Other financing activities over 5 years is $2.1 million, with a median of -$1000.0 recorded in 2013.
  • Peak YoY movement for Other financing activities: skyrocketed 1160100.0% in 2015, then tumbled 8459.52% in 2016.
  • A 5-year view of Other financing activities shows it stood at -$755000.0 in 2012, then soared by 99.87% to -$1000.0 in 2013, then changed by 0.0% to -$1000.0 in 2014, then skyrocketed by 12700.0% to $126000.0 in 2015, then soared by 8459.52% to $10.8 million in 2016.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $10.8 million in Q4 2016, -$10.8 million in Q3 2016, and $10.0 million in Q1 2016.